The Forces Behind Cell Movement

by Revathi Ananthakrishnan, Allen Ehrlicher
Published 2007-01-01

Pharmacological modeling and biostatistical analysis of a new drug

by Revathi Ananthakrishnan, Philimon Gona
Published 2010-04-01

2D (2 Dimensional) TEQR design for Determining the optimal Dose for safety and efficacy

by Revathi Ananthakrishnan, Stephanie Green, Daniel Li, Michael LaValley
Published 2019-12-01

Extensions of the mTPI and TEQR designs to include non-monotone efficacy in addition to toxicity for optimal dose determination for early phase immunotherapy oncology trials

by Revathi Ananthakrishnan, Stephanie Green, Daniel Li, Michael LaValley
Published 2018-06-01

Systematic comparison of the statistical operating characteristics of various Phase I oncology designs

by Revathi Ananthakrishnan, Stephanie Green, Mark Chang, Gheorghe Doros, Joseph Massaro, Michael LaValley
Published 2017-03-01